Daiwa Securities Group Inc. Sells 283 Shares of HCA Healthcare, Inc. (NYSE:HCA)

Daiwa Securities Group Inc. reduced its position in shares of HCA Healthcare, Inc. (NYSE:HCA) by 0.7% in the 3rd quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The firm owned 37,496 shares of the company’s stock after selling 283 shares during the period. Daiwa Securities Group Inc.’s holdings in HCA Healthcare were worth $15,240,000 at the end of the most recent quarter.

Several other institutional investors and hedge funds also recently modified their holdings of the company. Darsana Capital Partners LP boosted its position in shares of HCA Healthcare by 53.3% during the second quarter. Darsana Capital Partners LP now owns 1,150,000 shares of the company’s stock worth $369,472,000 after buying an additional 400,000 shares during the period. TD Asset Management Inc boosted its position in HCA Healthcare by 2.7% during the second quarter. TD Asset Management Inc now owns 741,130 shares of the company’s stock valued at $238,110,000 after purchasing an additional 19,812 shares during the last quarter. Epoch Investment Partners Inc. boosted its position in HCA Healthcare by 16.4% during the second quarter. Epoch Investment Partners Inc. now owns 631,854 shares of the company’s stock valued at $203,002,000 after purchasing an additional 88,948 shares during the last quarter. National Pension Service boosted its position in HCA Healthcare by 11.9% during the third quarter. National Pension Service now owns 550,654 shares of the company’s stock valued at $223,802,000 after purchasing an additional 58,353 shares during the last quarter. Finally, Dimensional Fund Advisors LP boosted its position in HCA Healthcare by 2.3% during the second quarter. Dimensional Fund Advisors LP now owns 520,835 shares of the company’s stock valued at $167,426,000 after purchasing an additional 11,861 shares during the last quarter. 62.73% of the stock is owned by institutional investors and hedge funds.

Analyst Upgrades and Downgrades

Several research analysts recently commented on the company. TD Cowen reduced their price target on HCA Healthcare from $450.00 to $440.00 and set a “buy” rating for the company in a research report on Monday, October 28th. Cantor Fitzgerald restated an “overweight” rating and issued a $392.00 price objective on shares of HCA Healthcare in a research note on Tuesday, October 1st. Oppenheimer upped their price objective on HCA Healthcare from $390.00 to $400.00 and gave the company an “outperform” rating in a research note on Monday, October 28th. Wells Fargo & Company upped their price objective on HCA Healthcare from $395.00 to $400.00 and gave the company an “equal weight” rating in a research note on Wednesday, November 6th. Finally, Royal Bank of Canada upped their price objective on HCA Healthcare from $378.00 to $405.00 and gave the company an “outperform” rating in a research note on Friday, August 23rd. Six research analysts have rated the stock with a hold rating, twelve have issued a buy rating and two have assigned a strong buy rating to the stock. According to MarketBeat.com, HCA Healthcare has a consensus rating of “Moderate Buy” and a consensus price target of $385.00.

Insider Buying and Selling at HCA Healthcare

In other HCA Healthcare news, SVP Phillip G. Billington sold 3,897 shares of HCA Healthcare stock in a transaction dated Thursday, November 14th. The stock was sold at an average price of $350.00, for a total transaction of $1,363,950.00. Following the transaction, the senior vice president now directly owns 52,702 shares of the company’s stock, valued at approximately $18,445,700. The trade was a 6.89 % decrease in their position. The sale was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through this link. Also, EVP Michael S. Cuffe sold 8,358 shares of HCA Healthcare stock in a transaction dated Thursday, September 12th. The stock was sold at an average price of $385.42, for a total value of $3,221,340.36. Following the transaction, the executive vice president now directly owns 29,678 shares in the company, valued at $11,438,494.76. The trade was a 21.97 % decrease in their ownership of the stock. The disclosure for this sale can be found here. In the last quarter, insiders have sold 15,155 shares of company stock valued at $5,608,990. 1.70% of the stock is currently owned by corporate insiders.

HCA Healthcare Price Performance

HCA Healthcare stock opened at $324.93 on Monday. The stock’s fifty day moving average price is $379.40 and its two-hundred day moving average price is $358.70. The firm has a market cap of $82.30 billion, a PE ratio of 14.59, a price-to-earnings-growth ratio of 1.25 and a beta of 1.68. HCA Healthcare, Inc. has a one year low of $245.84 and a one year high of $417.14. The company has a debt-to-equity ratio of 48.71, a current ratio of 1.12 and a quick ratio of 1.00.

HCA Healthcare Dividend Announcement

The firm also recently announced a quarterly dividend, which will be paid on Friday, December 27th. Shareholders of record on Friday, December 13th will be issued a $0.66 dividend. This represents a $2.64 dividend on an annualized basis and a dividend yield of 0.81%. The ex-dividend date is Friday, December 13th. HCA Healthcare’s dividend payout ratio is presently 11.85%.

HCA Healthcare Company Profile

HCA Healthcare, Inc, through its subsidiaries, owns and operates hospitals and related healthcare entities in the United States. It operates general and acute care hospitals that offers medical and surgical services, including inpatient care, intensive care, cardiac care, diagnostic, and emergency services; and outpatient services, such as outpatient surgery, laboratory, radiology, respiratory therapy, cardiology, and physical therapy.